On May 4, 2018, Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. completed their business combination to form Amneal Pharmaceuticals, Inc. (“Amneal”). Shares of Impax (“IPXL”) ceased trading on the NASDAQ stock exchange on May 4, 2018. On May 7, 2018, shares of the new combined company, Amneal, began to trade on the New York Stock Exchange under the ticker “AMRX”.

Pursuant to the business combination agreement, each share of Impax common stock was converted into the right to receive one share of Amneal Class A common stock.

Amneal Pharmaceuticals

Click here for more information about Amneal www.amneal.com.

Click here to access the Investor Relations section of Amneal’s website https://investors.amneal.com